WY-50295 - CAS 123016-21-7

WY-50295 is an orally active and selective 5-lipoxygenase inhibitor. In rat whole blood leukocytes, WY-50295 inhibits LTB4 formation with an IC50 of 40 μM and an oral ED50 of 18 mg/kg. WY-50295 is applicable for research into asthma and other leukotriene-dependent conditions.

Lipoxygenase

Metabolism

122988

C23H19NO3

357.4

O(CC1=NC2=C(C=C1)C=CC=C2)C3=CC4=C(C=C([C@@H](C(O)=O)C)C=C4)C=C3

-20°C

Ice Packs

Small Compound